Literature DB >> 21057900

Thromboembolic risk and anticoagulation strategies in patients undergoing catheter ablation for atrial fibrillation.

Juan F Viles-Gonzalez1, Davendra Mehta.   

Abstract

Periprocedural thromboembolic and hemorrhagic events are complications of percutaneous radiofrequency catheter ablation (RFA) of atrial fibrillation (AF). The management of anticoagulation before and after RFA could play an important role in the prevention of these complications. The incidence of thromboembolic events varies from 1% to 5%, depending on the ablation and the anticoagulation strategy used in the periprocedural period. The scientific evidence behind the management of anticoagulation in patients with AF undergoing RFA is scarce and is mostly based on small studies and experts' consensus. It remains unclear whether catheter ablation for AF reduces the risk of stroke and obviates the need for anticoagulation after the procedure. Limited data are available regarding the risk of thromboembolism with and without warfarin after AF ablation. In this review we will review the most current evidence supporting the different strategies to reduce thromboembolic risk before, during, and after catheter ablation for AF.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21057900     DOI： 10.1007/s11886-010-0153-2

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  23 in total

1.  The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation.

Authors:  Sakis Themistoclakis; Andrea Corrado; Francis E Marchlinski; Pierre Jais; Erica Zado; Antonio Rossillo; Luigi Di Biase; Robert A Schweikert; Walid I Saliba; Rodney Horton; Prasant Mohanty; Dimpi Patel; David J Burkhardt; Oussama M Wazni; Aldo Bonso; David J Callans; Michel Haissaguerre; Antonio Raviele; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

Review 2.  How to recognize, manage, and prevent complications during atrial fibrillation ablation.

Authors:  Sanjay Dixit; Francis E Marchlinski
Journal:  Heart Rhythm       Date:  2006-11-30       Impact factor: 6.343

3.  Impact of the maze procedure on the stroke rate in patients with atrial fibrillation.

Authors:  J L Cox; N Ad; T Palazzo
Journal:  J Thorac Cardiovasc Surg       Date:  1999-11       Impact factor: 5.209

4.  Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

Authors:  Riccardo Cappato; Hugh Calkins; Shih-Ann Chen; Wyn Davies; Yoshito Iesaka; Jonathan Kalman; You-Ho Kim; George Klein; Andrea Natale; Douglas Packer; Allan Skanes; Federico Ambrogi; Elia Biganzoli
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12-07

5.  Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging.

Authors:  Oussama M Wazni; Antonio Rossillo; Nassir F Marrouche; Eduardo B Saad; David O Martin; Mandeep Bhargava; Dianna Bash; Salwa Beheiry; Mark Wexman; Domenico Potenza; Ennio Pisano; Raffaele Fanelli; Aldo Bonso; Sakis Themistoclakis; Demet Erciyes; Walid I Saliba; Robert A Schweikert; Johannes Brachmann; Antonio Raviele; Andrea Natale
Journal:  J Cardiovasc Electrophysiol       Date:  2005-06

6.  Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period.

Authors:  Oussama M Wazni; Salwa Beheiry; Tamer Fahmy; Conor Barrett; Steven Hao; Dimpi Patel; Luigi Di Biase; David O Martin; Mohamed Kanj; Mauricio Arruda; Jennifer Cummings; Robert Schweikert; Walid Saliba; Andrea Natale
Journal:  Circulation       Date:  2007-11-12       Impact factor: 29.690

7.  Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy.

Authors:  Ayman A Hussein; David O Martin; Walid Saliba; Deven Patel; Saima Karim; Omar Batal; Mustafa Banna; Michelle Williams-Andrews; Minerva Sherman; Mohamed Kanj; Mandeep Bhargava; Thomas Dresing; Thomas Callahan; Patrick Tchou; Luigi Di Biase; Salwa Beheiry; Bruce Lindsay; Andrea Natale; Oussama Wazni
Journal:  Heart Rhythm       Date:  2009-07-10       Impact factor: 6.343

8.  Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation.

Authors:  Daniel Scherr; Kavita Sharma; Darshan Dalal; David Spragg; Karuna Chilukuri; Alan Cheng; Jun Dong; Charles A Henrikson; Saman Nazarian; Ronald D Berger; Hugh Calkins; Joseph E Marine
Journal:  J Cardiovasc Electrophysiol       Date:  2009-12

9.  Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation.

Authors:  Daniel Scherr; Darshan Dalal; Karuna Chilukuri; Jun Dong; David Spragg; Charles A Henrikson; Saman Nazarian; Alan Cheng; Ronald D Berger; Theodore P Abraham; Hugh Calkins; Joseph E Marine
Journal:  J Cardiovasc Electrophysiol       Date:  2008-10-27

10.  Comparison of ability to identify left atrial thrombus by three-dimensional tomography versus transesophageal echocardiography in patients with atrial fibrillation.

Authors:  Wael A Jaber; Richard D White; Stacie A Kuzmiak; Janet M Boyle; Andrea Natale; Carolyn Apperson-Hansen; James D Thomas; Craig R Asher
Journal:  Am J Cardiol       Date:  2004-02-15       Impact factor: 2.778
View more
  7 in total

1.  Safety and efficacy outcomes of protamine administration for heparin reversal following cryoballoon-based pulmonary vein isolation.

Authors:  Kadri Murat Gurses; Duygu Kocyigit; Muhammed Ulvi Yalcin; Banu Evranos; Hikmet Yorgun; Mehmet Levent Sahiner; Ergun Baris Kaya; Mehmet Ali Oto; Necla Ozer; Kudret Aytemir
Journal:  J Interv Card Electrophysiol       Date:  2015-02-28       Impact factor: 1.900

Review 2.  Practical issues in the management of novel oral anticoagulants-cardioversion and ablation.

Authors:  Abhishek Maan; E Kevin Heist; Jeremy N Ruskin; Moussa Mansour
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

Review 3.  Complications of Radiofrequency Catheter Ablation for Atrial Fibrillation.

Authors:  Timir Baman; Rakesh Latchamsetty; Hakan Oral
Journal:  J Atr Fibrillation       Date:  2011-09-30

4.  Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.

Authors:  Daniel W Kaiser; Megan M Streur; Rangadham Nagarakanti; S Patrick Whalen; Christopher R Ellis
Journal:  J Interv Card Electrophysiol       Date:  2013-04-28       Impact factor: 1.900

5.  Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin.

Authors:  Sai V Konduru; Aamir A Cheema; Philip Jones; Yan Li; Brian Ramza; Alan P Wimmer
Journal:  J Interv Card Electrophysiol       Date:  2012-09-27       Impact factor: 1.900

6.  UBLED AF (Uninterrupted BLackpool EDoxaban vs Warfarin vs Rivaroxaban in Atrial Fibrillation/Flutter ablation) Study.

Authors:  Narendra Kumar; Noha Elbanhawy; Moinuddin Choudhury; Rahul Potluri; Shajil Chalil; Khalid Abozguia
Journal:  J Atr Fibrillation       Date:  2021-08-31

Review 7.  Impact of body mass index on procedural complications, procedure duration, and radiation dose in patients with atrial fibrillation undergoing radiofrequency ablation: A systematic review and meta-analysis.

Authors:  Menglu Liu; Kaibo Mei; Xiao Liu; Yujie Zhao
Journal:  Clin Cardiol       Date:  2020-06-03       Impact factor: 2.882
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.